Navigation Links
Rib-X Pharmaceuticals Expands License Agreement with Yale University on New Ribosome Technology
Date:12/8/2009

NEW HAVEN, Conn., Dec. 8 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel drugs for the treatment of serious multi-drug-resistant infections, announced today it has entered into a further license agreement with Yale University in the area of ribosome and antibiotic structure and function. Under the agreement, Rib-X will further explore the high resolution crystal structure of new ribosome technology elucidated by Dr. Thomas Steitz and colleagues at Yale.

Dr. Steitz, who was recently awarded the Nobel Prize in Chemistry for 2009 by The Royal Swedish Academy of Sciences, is Sterling Professor of Molecular Biophysics and Biochemistry at Yale University and a Howard Hughes Medical Institute Investigator. He is also a Rib-X Co-Founder and Chair of the Scientific Advisory Board of the Company.

"This high resolution structure will become an important additional tool in the discovery of new antibiotic agents," said Susan Froshauer, Ph.D., Rib-X's President and CEO. "This further license is a natural extension of our relationship with Yale, and builds upon Dr. Steitz's Nobel Prize winning work and, in turn, will increase our understanding, on an atomic level, of the binding properties of antibiotics to the ribosome."

About Rib-X Pharmaceuticals, Inc.

Rib-X Pharmaceuticals, Inc. is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The Company currently has two drug candidates: delafloxacin, which is ready to enter Phase 3 clinical trials, and radezolid, whose oral form has been tested for safety and efficacy in two Phase 2 trials. Delafloxacin is a broad-spectrum fluoroquinolone with potent activity against quinolone-resistant Gram-positive bacteria, including methicillin-resistant S. aureus (MRSA). Radezolid, a new oxazolidione dis
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
2. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
3. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
4. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
6. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
7. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
8. Rib-X Pharmaceuticals, Inc. Co-Founder, Thomas A. Steitz, Ph.D., Awarded the 2009 Nobel Prize in Chemistry
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)...  The fairness of the proposed acquisition of Thoratec ... ("St. Jude") is the subject of an investigation by ... firm.  The investigation is focusing on possible breaches of ... Board of Directors of THOR for agreeing to sell ... Company announced it had reached a definitive agreement for ...
(Date:7/27/2015)... BOULDER, Colo. , July 27, 2015 ... will report financial results for the fourth ... and hold a conference call to discuss ... Ron Squarer, Chief Executive Officer will lead ... 2015Time:9:00 a.m. Eastern TimeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code: ...
(Date:7/27/2015)... As per the new market report ... Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2021," ... 2014, growing at a CAGR of 13.2% from 2015 to ... The global bionics market is growing primarily due to ... to paralysis or amputation of body parts. In addition, increasing ...
Breaking Medicine Technology:WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4
... SCHAUMBURG, Ill., Sept. 30 Sagent Pharmaceuticals, Inc., ... that it has launched vinorelbine injection, USP, an ... of vinorelbine injection, USP in the United States ... shipping vinorelbine injection immediately. , "Sagent has launched ...
... ROCKLAND, Mass., Sept. 30 EMD Serono, ... today the submission of a New Drug Application (NDA) ... Cladribine Tablets, EMD Serono,s proprietary investigational oral formulation of ... with relapsing forms of multiple sclerosis (MS). Cladribine Tablets ...
Cached Medicine Technology:Sagent Pharmaceuticals Launches Vinorelbine Injection, USP 2EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States 2EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States 3EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States 4
(Date:7/27/2015)... Lexington, Kentucky (PRWEB) , ... July 28, 2015 ... ... KORT (Kentucky Orthopedic Rehab Team) as the sports medicine provider for the entire ... (ACHS). , According to ACHS Athletic Director Rick Sallee, “Student safety and ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association ... 2015 Professional Woman of the Year. Ms. Baum-Lappe is recognized with this prestigious ... women in the country, spanning virtually every industry and profession, the National Association ...
(Date:7/27/2015)... ... 27, 2015 , ... In a piece published July 22 on ... surgery and explained why people should not shy away from their own personal aspirations. ... the few and celebrate it for the modern wonder that it is.” This is ...
(Date:7/27/2015)... ... ... The Maricopa Community Colleges today announced a new program that ... into and complete college. , The “Bridging Success Initiative,” funded by the ... from across the valley. , The initiative advisory board has representatives from Arizona State ...
(Date:7/27/2015)... ... July 27, 2015 , ... In an ... hiking to its options. Already an industry leader because of its use ... lookout for the latest successful trends in helping people to overcome addiction and ...
Breaking Medicine News(10 mins):Health News:KORT Physical Therapy Named Sports Medicine Provider for Anderson County School System 2Health News:KORT Physical Therapy Named Sports Medicine Provider for Anderson County School System 3Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 2Health News:Maricopa Community Colleges Launch Program To Help Youth In Foster Care Finish College 3Health News:Hiking Adds Benefits to Recovery at Serenity Palms 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 3
... new class of drugs based on a widely used ... the laboratory and in mice, according to researchers. The ... treatment of these tumors. // ,Previous drugs ... same cell targets as hydroxyurea, but had serious side ...
... mantra of the media as dozens of people exposed to ... potent antibiotic. But if the supply dwindles, doctors say other ... previous generation's wonder drug: penicillin. Although alternatives exist, Cipro is ... , // ,It helped that Cipro was the ...
... An experimental anti-cancer drug has shown effectiveness in treating ... report. Researchers say the drug probably acts on many ... for treating other types of cancer. Dr. Antonio Fojo ... colleagues tested the drug, depsipeptide//, in patients with T-cell ...
... virus that kills at least 30 percent of its ... the globe more than two decades ago. Scientists retained ... and stored them in secure laboratories in Atlanta, Georgia, ... of many potential bioterrorism threats, but "perhaps it is ...
... warned doctors that doxycycline -- an antibiotic being prescribed ... -- can stunt fetal growth when taken by pregnant ... urged doctors to prescribe Cipro to pregnant women. The ... being overprescribed in the general population, possibly causing common ...
... drugs, statements about drug benefits are often overblown ... expected benefit; instead, they make an emotional appeal," ... New Hampshire. // ,Instead of telling ... medicine is going to prevent some outcome, these ...
Cached Medicine News:
... EXPRESS Seeding Cartridge System is a single-use, ... seeds and spacers into a Bard BrachyStar ... has a(n): outer radiation safety shield, inner ... spacers, integrally molded fitting that connects the ...
... Luna is a very easy to use ... in close co-operation with practising urologists as ... lower urinary tract dysfunctions. The system offers ... and flow during a natural bladder filling, ...
A compact mobile System Cart gives mobility within your department. The cart accomodates the Uromac Median data processor, desktop computer, printer and provides stowage space. Patient related transd...
... Dorado™ will exceed your expectations with ... flexible enough to be customized to meet ... your needs grow, Dorado™ can be upgraded ... such as video and database management, it ...
Medicine Products: